323 related articles for article (PubMed ID: 29935220)
1. T cell-intrinsic prostaglandin E
Lee J; Aoki T; Thumkeo D; Siriwach R; Yao C; Narumiya S
J Allergy Clin Immunol; 2019 Feb; 143(2):631-643. PubMed ID: 29935220
[TBL] [Abstract][Full Text] [Related]
2. Endogenous prostaglandin E
Samuchiwal SK; Balestrieri B; Raff H; Boyce JA
J Biol Chem; 2017 May; 292(20):8195-8206. PubMed ID: 28341741
[TBL] [Abstract][Full Text] [Related]
3. Prostaglandin E2 regulates Th17 cell differentiation and function through cyclic AMP and EP2/EP4 receptor signaling.
Boniface K; Bak-Jensen KS; Li Y; Blumenschein WM; McGeachy MJ; McClanahan TK; McKenzie BS; Kastelein RA; Cua DJ; de Waal Malefyt R
J Exp Med; 2009 Mar; 206(3):535-48. PubMed ID: 19273625
[TBL] [Abstract][Full Text] [Related]
4. Increased Th17 cells in the tumor microenvironment is mediated by IL-23 via tumor-secreted prostaglandin E2.
Qian X; Gu L; Ning H; Zhang Y; Hsueh EC; Fu M; Hu X; Wei L; Hoft DF; Liu J
J Immunol; 2013 Jun; 190(11):5894-902. PubMed ID: 23645882
[TBL] [Abstract][Full Text] [Related]
5. Concerted EP2 and EP4 Receptor Signaling Stimulates Autocrine Prostaglandin E
Mangelsen E; Rothe M; Schulz A; Kourpa A; Panáková D; Kreutz R; Bolbrinker J
Cells; 2020 May; 9(5):. PubMed ID: 32438662
[TBL] [Abstract][Full Text] [Related]
6. Metabolic regulation by prostaglandin E
Robb CT; Zhou Y; Felton JM; Zhang B; Goepp M; Jheeta P; Smyth DJ; Duffin R; Vermeren S; Breyer RM; Narumiya S; McSorley HJ; Maizels RM; Schwarze JKJ; Rossi AG; Yao C
Allergy; 2023 Mar; 78(3):714-730. PubMed ID: 36181709
[TBL] [Abstract][Full Text] [Related]
7. Elevated IL-38 inhibits IL-23R expression and IL-17A production in thyroid-associated ophthalmopathy.
Pan Y; Wang M; Chen X; Chen Y; Ai S; Wang M; Su W; Liang D
Int Immunopharmacol; 2021 Feb; 91():107300. PubMed ID: 33383445
[TBL] [Abstract][Full Text] [Related]
8. Effects of prostaglandin E2 on gene expression in primary osteoblastic cells from prostaglandin receptor knockout mice.
Li X; Pilbeam CC; Pan L; Breyer RM; Raisz LG
Bone; 2002 Apr; 30(4):567-73. PubMed ID: 11934647
[TBL] [Abstract][Full Text] [Related]
9. Prostaglandin E2 activates the mTORC1 pathway through an EP4/cAMP/PKA- and EP1/Ca2+-mediated mechanism in the human pancreatic carcinoma cell line PANC-1.
Chang HH; Young SH; Sinnett-Smith J; Chou CE; Moro A; Hertzer KM; Hines OJ; Rozengurt E; Eibl G
Am J Physiol Cell Physiol; 2015 Nov; 309(10):C639-49. PubMed ID: 26310818
[TBL] [Abstract][Full Text] [Related]
10. Activation of prostaglandin EP4 receptor attenuates the induction of cyclooxygenase-2 expression by EP2 receptor activation in human amnion fibroblasts: implications for parturition.
Lu JW; Wang WS; Zhou Q; Gan XW; Myatt L; Sun K
FASEB J; 2019 Jul; 33(7):8148-8160. PubMed ID: 30917001
[TBL] [Abstract][Full Text] [Related]
11. Decreased RORC-dependent silencing of prostaglandin receptor EP2 induces autoimmune Th17 cells.
Kofler DM; Marson A; Dominguez-Villar M; Xiao S; Kuchroo VK; Hafler DA
J Clin Invest; 2014 Jun; 124(6):2513-22. PubMed ID: 24812667
[TBL] [Abstract][Full Text] [Related]
12. Prostaglandin E2 stimulates cystogenesis through EP4 receptor in IMCD-3 cells.
Elberg D; Turman MA; Pullen N; Elberg G
Prostaglandins Other Lipid Mediat; 2012 May; 98(1-2):11-6. PubMed ID: 22503965
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of E-type prostanoid receptors 2 and 4 in microglia stimulated with lipopolysaccharide.
Bonfill-Teixidor E; Otxoa-de-Amezaga A; Font-Nieves M; Sans-Fons MG; Planas AM
J Neuroinflammation; 2017 Jan; 14(1):3. PubMed ID: 28086956
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandin E
Ohkura N; Yoshiba K; Yoshiba N; Oda Y; Edanami N; Ohshima H; Takenaka S; Okiji T; Noiri Y
J Endod; 2023 Apr; 49(4):410-418. PubMed ID: 36758673
[TBL] [Abstract][Full Text] [Related]
15. Prostaglandin E2 promotes proliferation of skeletal muscle myoblasts via EP4 receptor activation.
Mo C; Zhao R; Vallejo J; Igwe O; Bonewald L; Wetmore L; Brotto M
Cell Cycle; 2015; 14(10):1507-16. PubMed ID: 25785867
[TBL] [Abstract][Full Text] [Related]
16. Cooperativity of E-prostanoid receptor subtypes in regulating signaling and growth inhibition in human airway smooth muscle.
Michael JV; Gavrila A; Nayak AP; Pera T; Liberato JR; Polischak SR; Shah SD; Deshpande DA; Penn RB
FASEB J; 2019 Apr; 33(4):4780-4789. PubMed ID: 30601680
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the Signaling Modalities of Prostaglandin E2 Receptors EP2 and EP4 Reveals Crosstalk and a Role for Microtubules.
Vleeshouwers W; van den Dries K; de Keijzer S; Joosten B; Lidke DS; Cambi A
Front Immunol; 2020; 11():613286. PubMed ID: 33643295
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandin E2-Induced COX-2 Expressions via EP2 and EP4 Signaling Pathways in Human LoVo Colon Cancer Cells.
Hsu HH; Lin YM; Shen CY; Shibu MA; Li SY; Chang SH; Lin CC; Chen RJ; Viswanadha VP; Shih HN; Huang CY
Int J Mol Sci; 2017 May; 18(6):. PubMed ID: 28587064
[TBL] [Abstract][Full Text] [Related]
19. Prostaglandin E2 modulates IL-8 expression through formation of a multiprotein enhanceosome in human colonic epithelial cells.
Srivastava V; Dey I; Leung P; Chadee K
Eur J Immunol; 2012 Apr; 42(4):912-23. PubMed ID: 22531917
[TBL] [Abstract][Full Text] [Related]
20. Prostaglandin E
Goepp M; Crittenden S; Zhou Y; Rossi AG; Narumiya S; Yao C
Immunology; 2021 Dec; 164(4):777-791. PubMed ID: 34529833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
